Solitary castrate-resistant prostate cancer metastasis to adrenal gland with concordant intense avidity on PSMA and FDG PET

被引：7
|
作者：
McGeorge, Stephen [1 ,2 ]
Phillips, Reece [3 ]
Rukin, Nicholas J. [2 ,3 ]
Reynolds, Jamie [1 ]
Roberts, Matthew J. [1 ,2 ,3 ,4 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Urol, Butterfield St, Herston, Qld 4029, Australia
[2] Univ Queensland, Fac Med, Herston, Qld 4006, Australia
[3] Redcliffe Hosp, Dept Urol, Anzac Ave, Redcliffe, Qld 4020, Australia
[4] Univ Queensland, Clin Res Ctr, Fac Med, Bldg 71/918 RBWH Butterfield St, Herston, Qld 4029, Australia
来源：
UROLOGY CASE REPORTS | 2021年 / 38卷
关键词：
Prostate cancer; Prostate specific membrane antigen; PSMA; Fluorodeoxyglucose; FDG; Adrenalectomy;
D O I：
10.1016/j.eucr.2021.101696
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Isolated prostate cancer metastasis to the adrenal gland is rare. We report a case of concordant high uptake in a solitary adrenal metastasis on both prostate-specific membrane antigen and fluorodeoxyglucose positron-emission tomography in a patient with castrate-resistant prostate cancer. Good initial biochemical response was achieved with lapamscopic adrenalectomy. The patient developed lymph node recurrence 12 months later, although remains asymptomatic on hormonal treatment 22 months post-operatively, in keeping with prior results for metastasis-directed therapy which can delay time to additional treatment. Application of dual tracer PET can be valuable for prostate cancer staging and guidance of metastasis-directed treatment.
引用
收藏
页数：3
相关论文
共 34 条
  • [21] Single Adrenal Metastasis From Prostate Cancer Detected by 68Ga-PSMA PET/CT and Confirmed by Biopsy A Case Report
    Braga Ribeiro, Andre Marcondes
    Pereira Lima, Eduardo Nobrega
    Garcia, Daniel
    Bezerra, Stephania Martins
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E61 - E62
  • [22] Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
    Ahmadzadehfar, Hojjat
    Rahbar, Kambiz
    Kuerpig, Stefan
    Boegemann, Martin
    Claesener, Michael
    Eppard, Elisabeth
    Gaertner, Florian
    Rogenhofer, Sebastian
    Schaefers, Michael
    Essler, Markus
    EJNMMI RESEARCH, 2015, 5 : 1 - 8
  • [23] Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
    Hojjat Ahmadzadehfar
    Kambiz Rahbar
    Stefan Kürpig
    Martin Bögemann
    Michael Claesener
    Elisabeth Eppard
    Florian Gärtner
    Sebastian Rogenhofer
    Michael Schäfers
    Markus Essler
    EJNMMI Research, 5
  • [24] Fluorocholine PET/CT parameters predictive for hematological toxicity to 223Radium therapy in castrate-resistant prostate cancer patients with bone metastases
    Sinigaglia, M.
    Zerdoud, S.
    Bastie, D.
    Dierickx, L.
    Racaru, L. Vija
    Courbon, F.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2018, 42 (02): : 70 - 77
  • [25] The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer—a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report
    Masha Maharaj
    Lucille Heslop
    Trisha Govender
    Nisaar Korowlay
    Aviral Singh
    Partha Choudhary
    Mike Sathekge
    Nuclear Medicine and Molecular Imaging, 2021, 55 : 136 - 140
  • [26] Combination of [68Ga]Ga-PSMA PET/CT and [18F]FDG PET/CT in demonstrating dedifferentiation in castration-resistant prostate cancer
    Kepenek, F.
    Can, C.
    Komek, H.
    Kaplan, I
    Gundogan, C.
    Ebinc, S.
    Guzel, Y.
    Aguloglu, N.
    Karaoglan, H.
    Tasdemir, B.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (04): : 193 - 199
  • [27] Large Paraesophageal Schwannoma With Intense Prostate-Specific Membrane Antigen Expression on 68Ga-PSMA-PET/CT Mimicking Lymph Node Metastasis in a Patient With Prostate Cancer
    Ries, Martin
    Khreish, Fadi
    Veith, Christian
    von den Hoff, Joachim
    Ezziddin, Samer
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (02) : 153 - 154
  • [28] Case Report: 18F-PSMA-1007 PET/CT Avid Solitary Penile Metastasis of Castration-Resistant Prostate Cancer With a PSA of 0.072 ng/ml
    Li, Yongliang
    Li, Yanmei
    Dong, Siying
    Chen, Jian
    Yang, Pengfei
    Li, Juan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer-a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report
    Maharaj, Masha
    Heslop, Lucille
    Govender, Trisha
    Korowlay, Nisaar
    Singh, Aviral
    Choudhary, Partha
    Sathekge, Mike
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (03) : 136 - 140
  • [30] B-CLL with negative 18F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases
    Jung, Theresa
    Neureiter, Daniel
    Schweighofer-Zwink, Gregor
    Rendl, Gundula
    Pirich, Christian
    Beheshti, Mohsen
    EJNMMI REPORTS, 2025, 9 (01)
1234